Navigation Links
Tibotec to Present Final Safety and Efficacy Results From Phase 2b PILLAR Study of Once-Daily TMC435 in Late-Breaker at AASLD
Date:11/5/2011

SAN FRANCISCO, Nov. 5, 2011 /PRNewswire/ -- Tibotec Pharmaceuticals (Tibotec), one of the Janssen (Janssen) Pharmaceutical Companies, today will present results of the final analysis of PILLAR, a phase 2b study of the investigational hepatitis C virus (HCV) NS3/4A protease inhibitor TMC435 in treatment-naive patients with chronic genotype 1 HCV, as part of a late-breaker oral presentation at the 62nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in San Francisco, CA, USA.  

Results from the final PILLAR analysis showed that TMC435 administered in combination with peginterferon alpha-2a and ribavirin (PR) resulted in significantly higher sustained virologic response (SVR) rates compared to placebo plus PR. In the two TMC435 treatment groups who received TMC435 75mg, between 75 and 82 percent of patients achieved SVR24, and in the two TMC435 treatment groups who received TMC435 150mg, between 81 and 86 percent of patients achieved SVR24. This is compared to 65 percent of patients in the placebo arm who achieved SVR24. In addition, 79 to 86 percent of patients in the TMC435 treatment arms had a shortened treatment duration of 24 weeks, compared to a 48 weeks treatment duration for patients who received placebo plus P/R. In TMC435 arms, 68 to 76 percent of patients achieved rapid virologic response [RVR; HCV RNA<25 (undetectable)], of whom 88 to 95 percent achieved SVR24. There were no significant differences for adverse events between TMC435 treatment groups and placebo. TMC435 150mg administered once daily (q.d.) is being investigated in phase 3 trials in treatment-naive patients and in patients who experienced a viral relapse after being treated with interferon-based therapy. TMC435 is being developed by Tibotec Pharmaceuticals. Medivir AB has commercialization rights for TMC435 for the Nordic countries, Janssen has commercialization rights for TMC435 in the rest of the world.

The PILLAR study ['/>"/>

SOURCE Tibotec Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
3. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
4. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
5. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
6. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
7. Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS
8. Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers
9. Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
10. Medivir Notes That Partner Tibotec Announced Week 24 Interim Results From Phase 2b TMC435 PILLAR Study to be Presented as a Late-Breaker at AASLD
11. Tibotec Signs Multiple Agreements With Generic Manufacturers to Provide Access to New HIV Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015  The Partnership to Fight Chronic Disease (PFCD) released a public ... and a new study analyzing the impact of increased cost sharing ... coalition working to educate policy makers and the public on the ... focused on how the Iowa healthcare exchange ...
(Date:1/23/2015)... Inc. (NASDAQ: NWBO )("NW Bio"), a U.S. biotechnology ... solid tumor cancers, announced today that CEO Linda Powers ... Immunotherapy Forum in Washington D.C. ... January 26 at 10:30 a.m. EST at the Grand Hyatt ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
... , , SAN DIEGO , Feb. ... that the jury in the litigation filed by Lightlab Imaging, Inc. ... Massachusetts , Suffolk County reached a verdict against ... 2008 , Volcano acquired Axsun, which had an agreement to supply ...
... , COLUMBUS, Ohio , Feb. 4 Mettler-Toledo International ... 2009.  Provided below are the highlights: , Sales in local ...  Reported sales growth was 0% due to a 5% benefit from currency. ... were $2.01 , compared with $1.84 in the fourth ...
Cached Medicine Technology:Volcano Corporation Announces Litigation Status 2Volcano Corporation Announces Litigation Status 3Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 2Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 3Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 4Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 5Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 6Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 7Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 8Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 9Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 10Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 11Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 12Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 13Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 14Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results 15
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 22, 2015 Juvent Sports ( http://www.juventsports.com ... 2015 PGA Merchandise Show to bestow a Juvent Sports ... amateur golfer, Arlene McKitrick. The award commemorated and congratulated ... tournament win. She won her first amateur tournament in ...
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... Wales health department in Australia chose to understand the relationship ... ,The study conducted over three years covered a gamut of ... that a greater proportion of people born in Italy and ... Zealanders were physically more active than other ethnic groups. People ...
... condition in children. Children suffering from insomnia //and hypersomnia ... normal sleep. ,Sleep-disturbed children, with both insomnia ... than those with either insomnia or hypersomnia. ... and colleagues of the University of Pittsburgh, 553 children ...
... lawsuits can significantly slow or halt science's ability ... //factors produced by industry, a team of scientists ... ,The authors caution that litigation's effects could seriously ... a wide variety of diseases, including Parkinson's disease, ...
... discovered that a tiny piece of genetic code apparently goes ... gets there under its own internal code. ,MicroRNAs, already ... gum up larger strands of RNA that carry instructions for ... are, says Joshua Mendell, M.D., Ph.D., an assistant professor in ...
... joining a sugar to a short-chain fatty acid compound, ... that kills cancer // cells in lab tests. The ... been tested on animals or humans. Nevertheless, they believe ... deadly disease. ,“For a long time, ...
... Preston Mason and colleagues at Elucida Research has ... in nature, shows significant promise as a viable ... disease based on its exceptional antioxidant properties in ... and anecdotal human data, the results of the ...
Cached Medicine News:Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 2Health News:Fast-Multiplying Lawsuits Can Stymie Medical Science, Authors Warn 3Health News:Renegade RNA: Clues to Cancer and Normal Growth 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 2Health News:Hybrid Molecule Causes Cancer Cells to Self-Destruct 3Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 2Health News:Study Finds Astaxanthin Is Potent Inhibitor of Oxidation in Cell Membrane Model 3
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
Comprehensive and structured clinical resource with access to more than 1,000 medical and surgical conditions, fully indexed with more than 7,500 items and medications....
... with BD Xstar Blade includes a specially ... blade in prodedure and handling. The ... grind-less process for manufacturing surgical blades. ... consistency. The arch style, single-bevel geometry ...
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists....
Medicine Products: